GlassScriptPhysician profile
Kristina Paley
NPI 1174729966
$1,298.25
in general payments reported to CMS, 2019-2025
12 companies · $357 in 2025
The $357 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $17.29 · 2021: $73.79 · 2022: $149 · 2023: $219 · 2024: $295 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $871.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $702.20 | 2019-2025 | |
| Genzyme Corporation | $153.76 | 2019-2025 | |
| Dermavant Sciences, INC. | $148.80 | 2023 | Vtama |
| Regeneron Healthcare Solutions, INC. | $67.98 | 2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $51.33 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $35.73 | 2023-2024 | Sotyktu |
| Janssen Biotech, INC. | $34.05 | 2021-2025 | Stelara, Tremfya, Simponi |
| Ucb, INC. | $25.95 | 2025 | Bimzelx |
| Amgen INC. | $24.49 | 2024 | Otezla |
| Leo Pharma INC. | $22.72 | 2024 | Adbry |
| Novartis Pharmaceuticals Corporation | $16.68 | 2019 | |
| Prugen, INC. Pharmaceuticals | $14.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristina Paley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.